Alterations of E-cadherin, α-catenin and β-catenin expression in neuroendocrine tumors of the gastrointestinal tract
✍ Scribed by Chiun Li; Bing Xu; Mitsuyoshi Hirokawa; Zhirong Qian; Katsuhiko Yoshimoto; Hidehisa Horiguchi; Takashi Tashiro; Toshiaki Sano
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 240 KB
- Volume
- 440
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Expression of the cell adhesion molecules including E-cadherin and its cytosolic binding proteins, -and -catenins, has been widely studied in a variety of tumours, but not, to date, in thymic epithelial tumours. To observe the expression pattern of these adhesion molecules, immunohistochemical stain
Previous in vitro and in vivo model studies have shown that when E-cadherin expression in carcinoma cells is reduced, invasive behaviour ensues. The situation in human cancer in vivo, however, appears to be more complex, as immunohistochemically determined E-cadherin expression in various carcinomas
Immunolocalization of E-cadherin (E-cad), ␣-catenin, -catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC). We, therefore, immunohistochemically examined the expression of E-cad, ␣-catenin, -catenin, CD44 standard (CD44s), and CD44 variants (CD44v) including CD44v5, CD44
Expression of the cell adhesion molecule, epithelial nism. The transmembrane linker glycoprotein that cadherin (E-CD) and its binding proteins, a-and b-caten-mediates this adhesion is thought to be epithelial cadins, in normal liver, chronic liver diseases, and hepatoherin (E-CD), the homophilic in